Milestone Pharmaceuticals, Inc. (MIST)
1.04
-0.02
(-1.42%)
USD |
NASDAQ |
Aug 24, 16:00
1.05
+0.01
(+0.96%)
After-Hours: 20:00
Milestone Pharmaceuticals Total Assets (Quarterly) : 181.62M for June 30, 2026
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 181.62M |
| March 31, 2026 | 193.73M |
| December 31, 2025 | 113.56M |
| September 30, 2025 | 87.75M |
| June 30, 2025 | 47.42M |
| March 31, 2025 | 61.88M |
| December 31, 2024 | 75.50M |
| September 30, 2024 | 82.71M |
| June 30, 2024 | 89.23M |
| March 31, 2024 | 96.00M |
| December 31, 2023 | 75.23M |
| September 30, 2023 | 87.12M |
| June 30, 2023 | 97.02M |
| March 31, 2023 | 111.08M |
| December 31, 2022 | 74.48M |
| Date | Value |
|---|---|
| September 30, 2022 | 85.77M |
| June 30, 2022 | 91.30M |
| March 31, 2022 | 105.80M |
| December 31, 2021 | 119.85M |
| September 30, 2021 | 133.78M |
| June 30, 2021 | 145.50M |
| March 31, 2021 | 138.44M |
| December 31, 2020 | 149.97M |
| September 30, 2020 | 108.80M |
| June 30, 2020 | 93.14M |
| March 31, 2020 | 105.16M |
| December 31, 2019 | 123.43M |
| September 30, 2019 | 141.89M |
| June 30, 2019 | 151.84M |
| March 31, 2019 | 77.59M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| InMed Pharmaceuticals, Inc. | 9.134M |
| NervGen Pharma Corp. | 63.57M |
| Clearmind Medicine, Inc. | 14.52M |
| Lexaria Bioscience Corp. | 4.781M |
| Target Group, Inc. (Canada) | 5.678M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 163.41M |
| Shareholders Equity (Quarterly) | 18.22M |
| Debt to Equity Ratio | 7.785 |
| Current Ratio | 8.129 |
| Net Debt Paydown Yield | -10.34% |